Chemring Group PLC

Chemring Group PLC

CMGMY
Chemring Group PLCUS flagOther OTC
6.79
USD
- -
- -
1.84BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
2.14
1.83
1.71
1.83
1.1
1.06
1.2
1.43
1.4
1.43
1.68
1.79
1.84
Basic EPS, GAAP
-0.22
-0.25
- -
0.04
0.02
-0.38
0.08
0.12
0.15
0.17
0.02
0.14
0.18
Free Cash Flow per Basic Share
0.16
0.11
0.04
0.18
0.06
0.05
0.06
0.12
0.16
0.16
0.11
0.05
-0.04
Dividend per Share
0.07
0.05
0.04
- -
0.02
0.03
0.03
0.04
0.04
0.05
0.06
0.07
0.08
Book Value per Share
0.79
0.44
0.4
0.48
0.42
0.04
0.04
0.11
0.21
0.32
0.23
0.2
0.3
Tangible Book Value per Share
0.21
0.28
0.27
0.62
0.66
0.44
0.52
0.62
0.71
0.91
0.89
0.84
0.81
Basic Weighted Avg Shares
221
221
221
261
279
280
280
281
282
281
282
273
271
Sales/Revenue/Turnover
472
403
377
477
307
297
335
402
393
401
473
488
498
Operating Margin (%)
-9.89
6.3
1.46
5.49
1.5
-5.35
9.34
11.5
12.81
12.32
9.61
11.59
14.75
Depreciation Expense
45
40
37
40
36
31
29
29
25
22
22
24
27
Net Income, GAAP
-48
-55
- -
11
7
-106
22
35
42
47
5
40
48
Effective Tax Rate (%)
- -
- -
- -
18.75
- -
- -
13.48
19.86
14.96
7.31
14.51
19.88
21.27
Profit Margin (%)
-10.23
-13.62
-0.11
2.33
2.15
-35.57
6.53
8.62
10.55
11.82
1.14
8.09
9.69
Working Capital
142
93
86
136
87
84
-9
57
46
68
42
100
130
LT Debt
261
156
161
121
62
91
8
61
30
25
20
53
104
Total Equity
384
300
291
413
401
294
306
330
353
418
378
356
382
Return on Invested Capital (%)
- -
- -
- -
4.12
- -
- -
6.96
9.35
10.63
10.64
8.89
10.27
11.37
Return on Capital (%)
- -
- -
- -
7.85
- -
- -
23.13
38.17
44.89
45.53
5.31
33.04
24.83
Return on Common Equity (%)
-23.43
-40.34
-0.43
10.46
5.48
-167.67
206.6
164.85
92.43
63.62
6.94
65.45
70.78

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.18%
3.48%
7.21%
Free Cash Flow
26.63%
-48.71%
-184.85%
Net Income, GAAP
-408.21%
119.74%
22.03%
Sales/Revenue/Turnover
4.32%
4.55%
1.88%
Total Cash Common Dividend
- -
16.05%
10.1%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
488
2025
- -
- -
- -
- -
498
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.14
2025
- -
- -
- -
- -
0.18
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.07
2025
- -
- -
- -
- -
0.08
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Michael Ord
Full Time Employees
2,672
Sector
Industrials
Industry
Aerospace & Defense
Address
Roke Manor Romsey HM United Kingdom SO51 0ZN
IPO Date
Dec 12, 2011
Business
Chemring Group PLC is a United Kingdom-based defence technology company specializing in the development, manufacture, and supply of advanced energetic material products, countermeasures, sensors, and information solutions for the aerospace, defence, security, and safety markets. The company operates primarily through two segments: Countermeasures & Energetics and Sensors & Information. Its Countermeasures & Energetics segment includes precision-engineered energetic devices, propellants, air and naval decoys, and explosive ordnance disposal products. The Sensors & Information segment focuses on electronic countermeasures, biological threat detection equipment, cyber, communications, AI-enabled sensor technologies, and advanced information advantage solutions. Chemring serves government, military, and security agencies globally, with operations spanning the UK, US, Europe, and Asia Pacific. Founded in 1905 and headquartered in Romsey, Hampshire, UK, the company employs approximately 2,700 people. In recent major developments, Chemring completed the acquisition of Landguard Nexus Limited and its subsidiaries in August 2025, a move that strengthens Chemring's Roke Manor business focused on UK sovereign defence, national security, and law enforcement solutions. The acquisition of Landguard, which specializes in tracking devices utilizing iridium, cellular, and RF technologies, enhances Chemring's portfolio in intelligence, surveillance, target acquisition, and reconnaissance (ISTAR) capabilities. In 2024, Chemring increased its investment in expanding energetic material production capacity from £120 million to £200 million and secured a record order book, highlighting strong demand across its product lines. The company continues to pursue strategic growth through organic investment and targeted acquisitions, with a live pipeline for expanding in cyber, information advantage, and US space and missile markets. Chemring also focuses on modernization, automation, and new product development aligned with evolving defence and security customer needs.

Company News

APIChatGPT
  • Defense ETFs Under Spotlight as UK Unveils $20B Military Overhaul

  • Defence sector rallies as Starmer confirms more spending on drones and nuclear deterrent

  • Chemring wins $345m of contracts with US Dept of War for airborne countermeasures

  • Chemring Group PLC (CMGMY) Q2 2026 Earnings Call Transcript

  • Chemring Group H1 Earnings Call Highlights

  • Chemring maintains guidance despite first-half profit dip

  • Chemring, Babcock and Avon top picks in defence sector, with BAE premium 'not justified'

  • Chemring shares fall 5% on back-end loaded outlook and US production setbacks

  • Chemring says full-year outlook on track despite slow start and US production disruption

  • Chemring Group PLC (CMGMY) Q4 2025 Earnings Call Transcript

  • Chemring shares slip as results arrive in line, capex to be hiked

  • Chemring Mulls Sale of U.S. Subsidiary Alloy Surfaces

  • Chemring says profits will be in line, as slower UK orders offsets defence demand

  • Chemring strikes acquisition deal for radio tracking specialist Landguard

  • Chemring Group: Innovating To Protect

  • Chemring Group PLC (CMGMF) Q2 2025 Earnings Call Transcript

  • Chemring shares rocket higher as results highlight UK strategic defence review opportunity

  • UK's Chemring posts record order book on geopolitical risks

  • Chemring holds the line on outlook as countermeasures growth offsets fall in sensor orders

  • BAE, QinetiQ, Chemring: Europe's defence boom looks far from over